DIRS.INFO The most relevant business & tech news

☆ Citi names its top biotech and pharma stock picks, giving one nearly 90% upside
▼ + stars: | 2023-05-17 | by ( Weizhen Tan | ) www.cnbc.com time to read: +2 min

The healthcare sector outperformed in Europe, India and China last month, according to Citi, which named its top picks worldwide. It gave Amylyx a price target of $53, giving it upside of around 88% from current levels. It gave Beam a price target of $60, implying upside of around 67%. Other European picks from Citi include Swiss healthcare company Roche and British pharma and biotech firm AstraZeneca . Asia stocks In Asia, Citi named Japanese pharmaceutical company Daiichi Sankyo , South Korean biotech firm Samsung Biologics and China's Wuxi Biologics as top picks.

REUTERS/Aly Song/File PhotoSYDNEY/HONG KONG, May 8 (Reuters) - Alibaba's (9988.HK) logistics arm aims to raise up to $2 billion via a listing in Hong Kong likely early next year, sources with knowledge of the matter said, bolstering hopes for a capital markets revival in the Asian financial hub. Cainiao, which has started work on the IPO, is looking to raise between $1 billion and $2 billion in Hong Kong, according to three sources. IPO PROSPECTSDealmakers hope that Cainiao's potential IPO, expected to be followed by market debuts from some of the other Alibaba units in the near-term, could help revive sluggish fundraising activities in Hong Kong. About $1.5 billion has been raised from IPOs in Hong Kong so far this year, marginally above the $1.2 billion raised in the same period last year, according to Refinitiv data. ($1 = 6.9149 Chinese yuan renminbi)Reporting by Scott Murdoch in Sydney and Julie Zhu in Hong Kong; Editing by Sumeet Chatterjee and Jamie FreedOur Standards: The Thomson Reuters Trust Principles.

☆ Consumers in China are dining at nicer restaurants — even if it costs $500 a person
▼ + stars: | 2023-05-05 | by ( Evelyn Cheng | ) www.cnbc.com time to read: +5 min

Despite the Covid-19 pandemic, a brand called Lu Style opened four new restaurants in the last three years in Beijing and Shanghai. Since Lu Style launched in 2016, more people no longer focus on just being able to eat, said Tian Junfeng, director of operations. Tian said Lu Style will be focused on improving customer service in the coming months. The 2023 rankings selected 304 restaurants — most of which were in China, including Lu Style. Two Lu Style locations have one Michelin star each, and the France-based guide includes more than 400 restaurants in mainland China.

Listed miners with lithium projects in South America suffered, however, on concerns other governments may follow Chile's lead. Elsewhere in Asia, lithium prices stabilised on an improved demand outlook, and Japan acted to shore up its EV minerals supply by announcing a swathe of industry subsidies. Bucking the regional trend were Australian-listed miners with projects in South America's lithium triangle which spans Chile, Argentina and Bolivia, on concerns other governments may follow Chile's footsteps. Shares in miners with Argentine projects fell. Lithium Power International, (LPI.AX) whose Maricunga brine project is Chile's largest permitted, proposed project welcomed the new policy which it said would "positively transform" Chile's lithium industry.

☆ Chinese officials step up foreign travel in race to find investors
▼ + stars: | 2023-04-06 | by ( Clare Jim | ) www.reuters.com time to read: +5 min

Their urgency highlights the pressure local governments face in boosting growth while burdened with cumulative debt of $9 trillion, said the sources who met Chinese officials in Hong Kong. The other executive and Yim said they had often attended as many as eight to 10 events a day with Chinese officials. Fengze, a district in the nearby city of Quanzhou, signed up procurement deals of up to 30 billion yuan from Hong Kong, the city's social media accounts showed. Shenzhen’s Boao district alone aims to attract 100 billion yuan in foreign investment this year, with 26 business managers and 10 officials responsible for key streets committing themselves to the task in a letter, Chinese media said. ($1=6.8810 Chinese yuan renminbi)Reporting by Clare Jim; Editing by Marius Zaharia and Clarence FernandezOur Standards: The Thomson Reuters Trust Principles.

But production is running at least a third below plan, keeping the Ariya from shipping to new customers, according to three of the people and production planning notes reviewed by Reuters. Implementation has proved "an extremely, extremely high challenge" and the advanced paint line has become a persistent headache, one of the people said. In a statement to Reuters, Nissan said Ariya production had faced challenges including supply of semiconductors, disruptions in components shipments and the factory's paint line. EVs accounted for just 4.5% of Nissan's global sales of 3.2 million vehicles in 2022. Output over the next two months is expected to fall short of that, according to production planning notes from last month reviewed by Reuters.

☆ China car sales plunge 38% in January as subsidies, tax cut end
▼ + stars: | 2023-02-08 | by ( ) www.reuters.com time to read: +2 min

SHANGHAI/BEIJING, Feb 8 (Reuters) - China's passenger car sales slumped 38% in January, reversing a 2.4% gain in the previous month, industry data showed on Wednesday, as demand weakened after a tax cut on combustion engine cars and subsidies on electric vehicles (EV) expired. Sales of new energy cars that include pure battery EVs and plug-in hybrids also fell 6.3% in January after a blistering 90% growth in 2022, the China Passenger Car Association (CPCA) said. "New energy car sales in January didn't meet our expectation, with a rare year-on-year decline in a single month sales," said Cui Dongshu, secretary general of CPCA in an online briefing on Wednesday. He said the Lunar New Year and the end of EV subsidies were among the factors leading to the decline. New energy vehicles accounted for a quarter of the total 1.3 million car sales in the month, CPCA data showed, down sharply from 35% in November 2022.

☆ Can Chinese stocks rally further? One investment bank thinks so — and names its top stock picks
▼ + stars: | 2023-01-31 | by ( Zavier Ong | ) www.cnbc.com time to read: +3 min

The recovery in Chinese stocks gained steam on Monday, as China's benchmark index came within striking distance of a bull market. Chinese stocks have been buoyed by Beijing's easing of Covid-19 restrictions and a waning regulatory crackdown. "We started the year with an overweight call on China, and while that is a consensus view, there are now concerns on China rally being too sharp/too quick. The extreme inflows in the past 3 months, indeed, pose a threat to the continuity of market rally for next 3 months," Bernstein analyst Rupal Agarwal wrote in a note on Jan. 27. Bernstein's screen for undervalued stocks that have underperformed the market rally tuned up a raft of names.

☆ Factbox: Chinese chipmakers caught in U.S.-China tech spat
▼ + stars: | 2023-01-31 | by ( Josh Horwitz | ) www.reuters.com time to read: +4 min

TSMC is the world's most valuable chipmaker and counts Apple Inc (AAPL.O) and Nvidia Corp (NVDA.O) among major clients. Its government-backing and ambition to make high-end chips caught the attention of the United States which put the firm on its Entity List in 2020. To date, most of SMIC's sales are made using the outdated 45 nanometer process node and above. Since late 2020, this specialisation in older chips has proven a boon due to a global shortage of lower-end chips. It produces DRAM at the 19 nanometer node and is moving into the 17 nanometer node - process nodes behind the industry leading-edge.

☆ Protesting Tesla China buyers vow more pressure over price cuts they missed
▼ + stars: | 2023-01-10 | by ( ) www.reuters.com time to read: +4 min

[1/4] Tesla owners unhappy with the U.S. carmaker's price cuts discuss their situation at a Tesla delivery centre in Shanghai, China January 10, 2023. Similar protests by Tesla owners have sprung up in cities including Henan, Wuxi and Hangzhou in recent days, according to owners and social media posts. Tesla has faced online backlash over previous price cuts in China before but nothing as widespread as the current spontaneous protests. "We trusted the brand so much that we cancelled our orders for other brands for Tesla," said Yu, who stayed with a group of about 25 protesters at the Tesla Shanghai facility late into Tuesday evening. Analysts have said Tesla's price cuts were almost certain to boost China sales, which tumbled in December, and force other EV makers to cut prices too.

☆ China’s reopening has gotten Wall Street excited. Here’s how the pros are playing it
▼ + stars: | 2023-01-10 | by ( Zavier Ong | ) www.cnbc.com time to read: +5 min

Over the past week, a host of Wall Street banks have turned increasingly bullish on the world's second-largest economy and have upgraded their outlook on Chinese stocks. Morgan Stanley expects China's GDP to grow by an "above-consensus" 5.4% in 2023, on the back of a "fast-tracked" reopening and more proactive policy easing. Meanwhile, UBS says Chinese stocks look increasingly attractive. How to play the reopening Against this backdrop, analysts have named a slew of both Chinese and global stocks they think will benefit most from China's reopening. Bank of America's domestic reopening beneficiaries include consumer stocks such as alcoholic beverage makers Kweichow Moutai and Tsingtao Brew , airline stocks including China Southern Airlines , as well as online travel platform Trip.com .

☆ U.S. and China Suddenly Play a Bit Nicer—Except in Chips
▼ + stars: | 2022-12-19 | by ( Jacky Wong | ) www.wsj.com time to read: 1 min

The U.S. removed 25 Chinese companies from its ‘unverified list,’ including Wuxi Biologics, which provides research and manufacturing services to drug companies. The past week has delivered clear signs of a modest thaw in U.S.-China trade and financial relations, which have long been in the deep freeze. Investors in Chinese shares—particularly U.S.-listed stocks and in certain technology sectors—can celebrate. But the chip sector is a different story: No-holds-barred competition between Washington and Beijing is here to stay.

☆ Biden blacklists China's YMTC, crackdowns on AI chip sector
▼ + stars: | 2022-12-15 | by ( Alexandra Alper | ) www.reuters.com time to read: +5 min

WASHINGTON, Dec 15 (Reuters) - The Biden administration on Thursday added Chinese memory chipmaker YMTC and 21 "major" Chinese players in the artificial intelligence chip industry to a trade blacklist, broadening its crackdown on China's chip industry. It also comes as Congress prepares to finalize legislation to bar the U.S. government from buying products that contain semiconductors made by YMTC, Chinese memory chipmaker CXMT or China's top chip manufacturer SMIC. The Commerce Department on Thursday also targeted nine Chinese entities for allegedly seeking to support China's military modernization, including Shanghai Micro Electronics Equipment Group Co Ltd (SMEE), China's only lithography company. Two of the Chinese companies removed from the unverified list - YMTC and SMEE- were added to the entity list. Being added to the unverified list forces U.S. suppliers to perform greater due diligence before shipping to the targeted companies.

"This falls into the category of a game changing view of Chinese companies because the threat of their delisting seems to have been eliminated," said Art Hogan, chief market strategist at B. Riley Financial. However, the relief was not seen in Thursday's trading for U.S.-listed shares of Chinese companies, which were higher amid the news, but gave up gains and some ended sharply lower. Washington and Beijing reached a landmark deal in August to settle a long-running dispute over auditing compliance of U.S.-listed Chinese firms. Authorities in China have long been reluctant to let overseas regulators inspect local accounting firms, citing national security concerns. U.S. lawmakers in 2020 agreed to legislation that would oust Chinese companies from U.S. stock exchanges unless they adhere to American auditing standards.

☆ Morgan Stanley turns bullish on China stocks, giving them serious upside potential
▼ + stars: | 2022-12-06 | by ( Weizhen Tan | ) www.cnbc.com time to read: +2 min

Morgan Stanley has turned bullish on China stocks for the first time in nearly two years as the country embarks on a "clear path set towards reopening." It had held its equal weight rating on Chinese stocks since Jan. 2021 and was last overweight on China in March 2020. Morgan Stanley also gave the major Chinese stock indexes large potential upsides. Morgan Stanley recommended investing in offshore Chinese stocks. Stocks set to benefit Morgan Stanley highlighted a list of stocks it said are set to benefit from the easing in China.

☆ China’s second-largest chipmaker poised for $2.5 billion IPO in Shanghai
▼ + stars: | 2022-11-07 | by ( ) www.reuters.com time to read: +2 min

SHANGHAI, Nov 7 (Reuters) - Chinese chip manufacturer Hua Hong Semiconductor Ltd (1347.HK) has received regulatory approval for an 18 billion yuan ($2.5 billion) IPO in Shanghai, according to a filing published late on Friday on the Hong Kong stock exchange. The proceeds from the IPO will also go to upgrading the latter fab, according to its prospectus. Hua Hong’s Shanghai IPO will follow that of China’s Semiconductor Manufacturing International Corp (SMIC) (0981.HK), which, like Hua Hong, went public on Shanghai’s tech-centric STAR market in 2020 after it listed in Hong Kong years earlier. Hua Hong’s planned IPO comes after Washington passed unprecedented export controls on Chinese chip makers. Hua Hong specializes in mature technology, and generates most of its revenue making chips using 55-nanometer process technology.

Investors looked beyond the bleak outlook to welcome the aggressive investment cut, sending SK Hynix shares 1.7% higher in a bet the scale of the action would help control chip oversupply and prop up chip prices. SK Hynix said its operating profit fell to 1.66 trillion won ($1.16 billion) in the July-September quarter, from 4.2 trillion won a year earlier. The result was below analysts' expectations of a 1.87 trillion won profit, according to Refinitiv SmartEstimate. SK Hynix said its 2022 investment is expected to be at the "upper range of 10-20 trillion won ($7-14 billion)", meaning 2023 investments could fall below 10 trillion won. SK Hynix also warned of uncertainties involving its chip plants in China due to U.S. export restrictions on advanced chip equipment to China aimed at slowing Beijing's technological advances.

☆ U.S. aims to hobble China’s chip industry with sweeping new export rules
▼ + stars: | 2022-10-07 | by ( ) www.nbcnews.com time to read: +4 min

The raft of measures could amount to the biggest shift in U.S. policy toward shipping technology to China since the 1990s. If effective, they could set China’s chip manufacturing industry back years by forcing American and foreign companies that use U.S. technology to cut off support for some of China’s leading factories and chip designers. On Friday, the Biden administration applied the expanded restrictions to China’s IFLYTEK, Dahua Technology, and Megvii Technology, companies added to the entity list in 2019 over allegations they aided Beijing in the suppression of its Uigher minority group. The “unverified list” is a potential stepping stone to tougher economic blacklists, but companies that comply with U.S. inspection rules can come off the list. On Friday, U.S. officials removed nine such firms, including China’s Wuxi Biologics, which makes ingredients for AstraZeneca’s Covid-19 vaccine.

Companies are added to the unverified list because the United States could not complete on-site visits to determine whether they can be trusted to receive sensitive technology exports from the United States. U.S. inspections of Chinese companies require the approval of China's commerce ministry. Under the Biden administration's new policy, if a government prevents U.S. officials from conducting site checks at companies placed the unverified list, Washington will start the process for adding them to the entity list after 60 days. The United States removed a unit of Wuxi Biologics, maker of ingredients for AstraZeneca's COVID-19 vaccine, from the unverified list. The company looks forward to scheduling an inspection of its Shanghai subsidiary, which also was placed on the unverified list in February, she added.

REUTERS/Evelyn HocksteinHONG KONG, Sept 14 (Reuters Breakingviews) - China biotech’s American honeymoon is ending. Key to his initiative is ensuring that “biotechnologies invented in the United States of America are made in the United States of America”. With more bad news set to trickle out of Washington, Chinese biotech companies have a bitter pill to swallow. The order "directs the federal government to ensure biotechnologies invented in the United States of America are made in the United States of America," Biden said. Hong Kong shares of WuXi Biologics, a Chinese contract drug manufacturer, closed down 20% on Sept. 13 to HK$53.40.

☆ Housing might be struggling in China but there are green shoots in commercial property
▼ + stars: | 2022-09-13 | by ( Su-Lin Tan | ) www.cnbc.com time to read: +7 min

Commercial property is a bright spot in Chinese real estate, in contrast with the doom and gloom of the residential housing market. Likewise, property group CIFI Holdings posted a 23% year-on-year drop in home sales in China for the first half, but reported a 69.5% lift in its property investment revenue. While some investors sold assets to stay liquid, Spiro said the commercial sector generally has more supportive government and fiscal policies. All in all, the Chinese commercial property sector's resilience lies in its ability to rebound faster than its residential counterpart. Down but not outBut unlike housing, the commercial sector is rebounding particularly after lockdowns ended and government incentives kicked in, CBRE said.

Search resuls for: "WuXi"

21 mentions found